Header Logo

Connection

Nirav Shah to Clinical Trials, Phase I as Topic

Back to Details
This is a "connection" page, showing publications Nirav Shah has written about Clinical Trials, Phase I as Topic.
Nirav Shah
Connection Strength
0.055
Clinical Trials, Phase I as Topic
  1. Safety of Extended Pirtobrutinib Exposure in Relapsed and/or Refractory B-Cell Malignancies. Acta Haematol. 2025; 148(2):180-197.
    View in: PubMed
    Score: 0.055
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.